NASDAQ OMX Welcomes Xvivo Perfusion to First North

10/8/2012 5:00 AM EST

NASDAQ OMX Nordic

NASDAQ OMX Welcomes Xvivo Perfusion to First North

Stockholm, October 8 2012 — NASDAQ OMX (NASDAQ: NDAQ) announces that the
trading in Xvivo Perfusion AB (short name: XVIVO) shares will commence today on
First North at NASDAQ OMX Stockholm. Xvivo Perfusion, which is a spin-off
company from main market listed Vitrolife AB, belongs to the Healthcare sector
and is the sixth new company to be admitted to trading on First North in 2012. 

Xvivo Perfusion is a medical technology company focused on developing optimized
solutions for organ and tissue preservation in connection with transplantation.
The company delivers solutions and systems that can increase organ
availability, improve the transplant process outcome and enhance the long-term
outcomes and quality of life of the transplant recipient. 

Magnus Nilsson, CEO of Xvivo Perfusion, said: “Through our listing at First
North we expect to gain increased and more focused exposure for our unique
solutions towards both private and institutional investors. We operate in a
market with tremendous potential and look forward to leveraging our public
listing in order to build our brand and support continued financial growth.” 

Emelie Jarnesten, head of NASDAQ OMX First North, commented: “We welcome Xvivo
Perfusion to First North, one of Europe’s most liquid growth markets. The
company is a welcome addition to the Healthcare sector and we look forward to
supporting them by maximizing its exposure to both local and global investor
communities.” 

Xvivo Perfusion has appointed Redeye as Certified Adviser.

To view a CEO interview from the Xvivo Perfusion listing ceremony click here.

                                      - # -

About First North
First North is regulated as a multilateral trading facility, operated by the
different exchanges within NASDAQ OMX Nordic. It does not have the legal status
as an EU-regulated market. Companies at First North are subject to the rules of
First North and not the legal requirements for admission to trading on a
regulated market. The risk in such an investment may be higher than on the main
market. 


About NASDAQ OMX Group
The inventor of the electronic exchange, The NASDAQ OMX Group, Inc., fuels
economies and provides transformative technologies for the entire lifecycle of
a trade - from risk management to trade to surveillance to clearing. In the
U.S. and Europe, we own and operate 24 markets, 3 clearinghouses and 5 central
securities depositories supporting equities, options, fixed income,
derivatives, commodities, futures and structured products. Able to process more
than 1 million messages per second at sub-40 microsecond speeds with 99.999%
uptime, our technology drives more than 70 marketplaces in 50 developed and
emerging countries into the future, powering 1 in 10 of the world’s securities
transactions. Our award-winning data products and worldwide indexes are the
benchmarks in the financial industry. Home to approximately 3,400 listed
companies worth $6 trillion in market cap whose innovations shape our world, we
give the ideas of tomorrow access to capital today. Welcome to where the world
takes a big leap forward, daily. Welcome to the NASDAQ OMX Century. To learn
more, visit www.nasdaqomx.com. Follow us on Facebook
(http://www.facebook.com/NASDAQ) and Twitter
(http://www.twitter.com/nasdaqomx). (Symbol: NDAQ and member of S&P 500) 


Cautionary Note Regarding Forward-Looking Statements

The matters described herein contain forward-looking statements that are made
under the Safe Harbor provisions of the Private Securities Litigation Reform
Act of 1995. These statements include, but are not limited to, statements about
NASDAQ OMX's products and offerings. We caution that these statements are not
guarantees of future performance. Actual results may differ materially from
those expressed or implied in the forward-looking statements. Forward-looking
statements involve a number of risks, uncertainties or other factors beyond
NASDAQ OMX's control. These factors include, but are not limited to factors
detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed
with the U.S. Securities and Exchange Commission. We undertake no obligation to
release any revisions to any forward-looking statements. 



Media contact:
Carl Norell
+46 8 405 66 39